Pila Pharma AB (publ) (OM: PILA)
Health Care · Pharmaceuticals · SE
Skr1.70
+5.26% today · -29.2% 1Y
Pila Pharma AB (publ) (OM: PILA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $7.38M and employs 1 people.
Over the last twelve months the share price has lost 29.2%, trading between 1.02 and 2.50.
Tweenvest scores Pila Pharma AB (publ) across four factors: quality 35/100, value 38/100. Its strongest factor is value.
PILA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.38M
- Revenue (TTM)
- $28.45K
- P/E
- —
- EPS
- -0.43
- Dividend yield
- —
- Beta (5Y)
- -0.51
- 52-week high
- Skr2.50
- 52-week low
- Skr1.02
- Avg volume (3M)
- —
- Shares outstanding
- 45.68M
- Employees
- 1
- Next earnings
- —
About Pila Pharma AB (publ)
Based in Sweden, PILA PHARMA AB (publ) is a pharmaceutical firm actively engaged in clinical development. The company's principal drug, XEN-D0501, is a TRPV1 antagonist which has successfully completed two phase 2a clinical studies aimed at treating type 2 diabetes. PILA PHARMA AB (publ) was founded in 2014 and maintains its headquarters in Malmö, Sweden.
- ISIN
- SE0015988274
- Founded
- 2014
- Listed since
- Jul 15, 2021
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sunil Healthcare LimitedBSE: 537253 | $7.68M | Rs72.50 | +6.30% |
| Protect Pharmaceutical CorporationOTCPK: PRTT | $7.47M | $0.13 | -23.53% |
| Source Natural Foods and Herbal Supplements LimitedBSE: 531398 | $7.47M | Rs112.25 | +4.52% |
| Vineet Laboratories LimitedNSEI: VINEETLAB | $7.43M | Rs37.45 | +4.29% |
| Incanthera plcOFEX: INC | $7.33M | £0.04 | -10.98% |
| Zenith Drugs LimitedNSEI: ZENITHDRUG | $7.19M | Rs40.60 | -3.45% |
| Onyx Biotec LimitedNSEI: ONYX | $7.12M | Rs38.00 | +1.20% |
| Cann Group LimitedASX: CAN | $6.95M | AU$0.01 | +33.33% |
Figures last refreshed Oct 11, 2026.